Skip to main content

ABCD Spring Meeting, Solihull, 2013, abstract 1

1 Combined insulin and liraglutide therapy is associated with metabolic improvement and reduction in insulin dose in commonly prescribed insulin regimens: an ABCD liraglutide audit analysis

Piya Sen Gupta1,2, Ken-Yang Thong1, Robert EJ Ryder1on behalf of the ABCD liraglutide audit contributors.

1Departments of Diabetes, City Hospital, Birmingham UK

2Department of Diabetes, King’s College London, UK

ABCD Autumn Meeting, London, 2010b - Abstract

Problems with the NICE guideline for exenatide exposed in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide audit

R.E.J. Ryder1, K.Y. Thong1, M.L. Cull1, A.P. Mills1, C. Walton2, K.A. Adamson3, D.S. Dove4, on behalf of the ABCD nationwide exenatide audit contributors

1City Hospital, Birmingham, United Kingdom

2Hull Royal Infirmary, Hull, United Kingdom

3St John's Hospital, Livingston, United Kingdom

Opportunity for ABCD Members feedback on the forthcoming ADA conference

An opportunity for our consultants to feedback valuable nuggets from the forthcoming ADA conference on 12-16th June has become available via the Diabetes Professional Conference (DPC).

This would take an interview style format in an area of interest. For those attending and who are interested, please promptly contact Toby Baker, Event Director at DPC Tobyb@diabetespc.com